Poly Medicure closes trading window ahead of Q2FY27 results
- Trading window closed from October 1, 2026
- Closure lasts until 48 hours after Q2FY27 results declaration
- Compliance with SEBI insider trading regulations cited
- Board meeting date for results to be announced later

*this image is generated using AI for illustrative purposes only.
Poly Medicure Limited has closed its trading window for designated persons starting October 1, 2026. The closure will remain in effect until 48 hours after the declaration of financial results for the quarter and half-year ended September 30, 2026.
Regulatory Compliance
The company stated that this action complies with the SEBI (Prohibition to Insider Trading) Regulations, 2015, as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018. The decision also adheres to clarifications provided by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated April 2, 2019, and NSE letter ref no: NSE/CML/2019/11 dated April 2, 2019.
Additionally, the closure follows the company's Code of Conduct for prevention of insider trading. The move ensures that designated persons do not trade in the company's securities while in possession of unpublished price-sensitive information regarding the upcoming quarterly results.
Board Meeting Schedule
The date of the Board Meeting to consider and approve the financial results for the period ending September 30, 2026, will be intimated to the stock exchanges in due course. The company notified BSE Limited and National Stock Exchange of India Limited of this development on September 28, 2026.
Historical Stock Returns for Poly Medicure
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.02% | -5.02% | -5.37% | +37.69% | -15.82% | +76.89% |
How might the upcoming Q2 FY27 results influence Poly Medicure's valuation multiples given recent trends in the medical device sector?
What specific product segments within Poly Medicure's portfolio are expected to drive revenue growth in the current quarter?
How will the company's international expansion strategy impact its margin profile in the coming fiscal year?


































